Impact of the COVID-19 pandemic on clinical trials with drugs.

Hasford, Joerg

Hasford, Joerg.

Hasford J; Institute for Medical Informatics, Biometry and Epidemiology, Ludwigs-Maximilians-Universitaet Muenchen , Muenchen, Germany.

Expert Opin Drug Saf ; 19(11): 1373-1375, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-792262

Subject(s)

Clinical Trials as Topic/organization & administration; Coronavirus Infections; Delivery of Health Care, Integrated/organization & administration; Infection Control/organization & administration; Pandemics; Pneumonia, Viral; Research Design; Research Personnel/organization & administration; COVID-19; Coronavirus Infections/diagnosis; Coronavirus Infections/epidemiology; Coronavirus Infections/therapy; Coronavirus Infections/transmission; Humans; Infectious Disease Transmission, Patient-to-Professional/prevention & control; Infectious Disease Transmission, Professional-to-Patient/prevention & control; Occupational Health; Patient Safety; Pneumonia, Viral/diagnosis; Pneumonia, Viral/epidemiology; Pneumonia, Viral/therapy; Pneumonia, Viral/transmission; Psychological Distance; Risk Factors

Keywords

clinical trials; clinical trials regulation; covid-19; pandemic; patient involvement

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Research Design / Research Personnel / Clinical Trials as Topic / Infection Control / Coronavirus Infections / Delivery of Health Care, Integrated / Pandemics Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Expert Opin Drug Saf Journal subject: Pharmacology / Drug Therapy Year: 2020 Document Type: Article Affiliation country: 14740338.2020.1828861

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google